187 related articles for article (PubMed ID: 5720803)
1. Vaccines produced in diploid cell lines--discussion.
Perkins FT
Natl Cancer Inst Monogr; 1968 Dec; 29():495-7. PubMed ID: 5720803
[No Abstract] [Full Text] [Related]
2. Identification standards of primary cultures and diploid cell lines--discussion.
Stulberg CS
Natl Cancer Inst Monogr; 1968 Dec; 29():15-9. PubMed ID: 5720789
[No Abstract] [Full Text] [Related]
3. Technology of production of primary and diploid cell cultures.
Brackett RG
Natl Cancer Inst Monogr; 1968 Dec; 29():33-4. PubMed ID: 5720801
[No Abstract] [Full Text] [Related]
4. Vaccines produced in heteroploid cell lines--discussion.
Hull RN
Natl Cancer Inst Monogr; 1968 Dec; 29():471-2. PubMed ID: 4976366
[No Abstract] [Full Text] [Related]
5. Karyologic characteristics of the WI-38 diploid cell system--general comments.
Rubin BA; Minecci LC; Tint H
Natl Cancer Inst Monogr; 1968 Dec; 29():97-104. PubMed ID: 5720816
[No Abstract] [Full Text] [Related]
6. Clinical experience with vaccines produced in the human diploid cell line WI-38.
Andzaparidze OG
Natl Cancer Inst Monogr; 1968 Dec; 29():477-84. PubMed ID: 4976367
[No Abstract] [Full Text] [Related]
7. Continuously propagated cell lines. Biochemical identification standards--discussion.
Peterson WD
Natl Cancer Inst Monogr; 1968 Dec; 29():55-7. PubMed ID: 5720808
[No Abstract] [Full Text] [Related]
8. Cell cultures for virus vaccine production. General conclusions from the conference.
Merchant DJ
Natl Cancer Inst Monogr; 1968 Dec; 29():583-4. PubMed ID: 5720811
[No Abstract] [Full Text] [Related]
9. Viral oncogenicity and viral vaccines--general comments.
Gerber P
Natl Cancer Inst Monogr; 1968 Dec; 29():447-8. PubMed ID: 4888932
[No Abstract] [Full Text] [Related]
10. Neoplastic properties of animal cell lines. Multiple-layered perfusion cultures.
Kruse PF
Natl Cancer Inst Monogr; 1968 Dec; 29():277-8. PubMed ID: 5720797
[No Abstract] [Full Text] [Related]
11. Large-scale production of indefinitely propagated cell lines.
Cooper PD
Natl Cancer Inst Monogr; 1968 Dec; 29():63-7. PubMed ID: 5720812
[No Abstract] [Full Text] [Related]
12. Neoplastic properties of animal cell lines. Methods for determining neoplastic properties--discussion.
Dawe CJ
Natl Cancer Inst Monogr; 1968 Dec; 29():229-32. PubMed ID: 5720795
[No Abstract] [Full Text] [Related]
13. Cell substrates for human virus vaccine preparation--general comments.
Hayflick L
Natl Cancer Inst Monogr; 1968 Dec; 29():83-91. PubMed ID: 5720814
[No Abstract] [Full Text] [Related]
14. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments.
Jensen KE
Natl Cancer Inst Monogr; 1968 Dec; 29():207-8. PubMed ID: 5720793
[No Abstract] [Full Text] [Related]
15. Experience with an established cell line for veterinary vaccine production.
Brown AL
Natl Cancer Inst Monogr; 1968 Dec; 29():523-6. PubMed ID: 4305440
[No Abstract] [Full Text] [Related]
16. Comments on technology of production--continuous cell lines.
Daniels WF
Natl Cancer Inst Monogr; 1968 Dec; 29():71-2. PubMed ID: 5720813
[No Abstract] [Full Text] [Related]
17. Continuously propagated cell lines. Identification standards: serology.
Brand KG
Natl Cancer Inst Monogr; 1968 Dec; 29():51-3. PubMed ID: 5720805
[No Abstract] [Full Text] [Related]
18. Characteristics of primary cultures and diploid cells--technology of production.
Holper JC
Natl Cancer Inst Monogr; 1968 Dec; 29():21-31. PubMed ID: 4976359
[No Abstract] [Full Text] [Related]
19. Neoplastic properties of animal cell lines--general comments.
Macpherson I
Natl Cancer Inst Monogr; 1968 Dec; 29():295-6. PubMed ID: 4976360
[No Abstract] [Full Text] [Related]
20. Viral flora of primate tissues--discussion.
Malherbe H
Natl Cancer Inst Monogr; 1968 Dec; 29():177-8. PubMed ID: 5720790
[No Abstract] [Full Text] [Related]
[Next] [New Search]